Dimensional Fund Advisors LP Immucell Corp Transaction History

Dimensional Fund Advisors LP

$376 Billion
Q2 2024

A detailed history of Dimensional Fund Advisors LP transactions in Immucell Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 66,069 shares of ICCC stock, worth $235,866. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,069

Previous 63,401 4.21%

Holding current value

$235,866

Previous $336,000 4.76%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$4.18 - $5.48 $11,152 - $14,620	2,668 Added 4.21%	66,069 $320,000
Q1 2024 May 10, 2024	BUY	$4.73 - $5.47 $28,143 - $32,546	5,950 Added 10.36%	63,401 $336,000
Q4 2023 Feb 07, 2024	SELL	$4.45 - $5.47 $636 - $782	-143 Reduced 0.25%	57,451 $292,000
Q3 2023 Nov 09, 2023	SELL	$4.53 - $5.61 $30,215 - $37,418	-6,670 Reduced 10.38%	57,594 $307,000
Q2 2023 Aug 09, 2023	SELL	$4.64 - $5.98 $1,971 - $2,541	-425 Reduced 0.66%	64,264 $321,000
Q1 2023 May 12, 2023	BUY	$4.85 - $7.84 $12,217 - $19,748	2,519 Added 4.05%	64,689 $333,000
Q4 2022 Feb 09, 2023	BUY	$6.09 - $8.25 $241,109 - $326,625	39,591 Added 175.34%	62,170 $379,000
Q3 2022 Nov 10, 2022	BUY	$7.04 - $9.1 $11,003 - $14,223	1,563 Added 7.44%	22,579 $169,000
Q2 2022 Aug 12, 2022	BUY	$7.7 - $10.71 $12,497 - $17,382	1,623 Added 8.37%	21,016 $183,000
Q4 2021 Feb 09, 2022	SELL	$8.0 - $9.74 $8,968 - $10,918	-1,121 Reduced 5.46%	19,393 $155,000
Q3 2021 Nov 12, 2021	BUY	$8.54 - $10.24 $9,445 - $11,325	1,106 Added 5.7%	20,514 $190,000
Q2 2021 Aug 12, 2021	BUY	$8.5 - $10.95 $36,652 - $47,216	4,312 Added 28.56%	19,408 $184,000
Q1 2021 May 14, 2021	BUY	$5.98 - $11.88 $90,274 - $179,340	15,096 New	15,096 $146,000

Others Institutions Holding ICCC

# of Institutions

Shares Held

1.13M

Call Options Held

Put Options Held

View Full List

About IMMUCELL CORP

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $27.7M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

More about ICCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Immucell Corp Transaction History